281 related articles for article (PubMed ID: 28128853)
21. Autoimmunity to citrullinated type II collagen in rheumatoid arthritis.
Yoshida M; Tsuji M; Kurosaka D; Kurosaka D; Yasuda J; Ito Y; Nishizawa T; Yamada A
Mod Rheumatol; 2006; 16(5):276-81. PubMed ID: 17039307
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
23. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation.
Foulquier C; Sebbag M; Clavel C; Chapuy-Regaud S; Al Badine R; Méchin MC; Vincent C; Nachat R; Yamada M; Takahara H; Simon M; Guerrin M; Serre G
Arthritis Rheum; 2007 Nov; 56(11):3541-53. PubMed ID: 17968929
[TBL] [Abstract][Full Text] [Related]
24. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
Burkhardt H; Sehnert B; Bockermann R; Engström A; Kalden JR; Holmdahl R
Eur J Immunol; 2005 May; 35(5):1643-52. PubMed ID: 15832289
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen.
Damgaard D; Senolt L; Nielsen MF; Pruijn GJ; Nielsen CH
Arthritis Res Ther; 2014 Dec; 16(6):498. PubMed ID: 25475141
[TBL] [Abstract][Full Text] [Related]
26. The Prominent Role of Hematopoietic Peptidyl Arginine Deiminase 4 in Arthritis: Collagen- and Granulocyte Colony-Stimulating Factor-Induced Arthritis Model in C57BL/6 Mice.
Fukui S; Gutch S; Fukui S; Cherpokova D; Aymonnier K; Sheehy CE; Chu L; Wagner DD
Arthritis Rheumatol; 2022 Jul; 74(7):1139-1146. PubMed ID: 35166055
[TBL] [Abstract][Full Text] [Related]
27. Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses.
Pratesi F; Panza F; Paolini I; Petrelli F; Puxeddu I; Casigliani-Rabl S; Ancillotti D; Alcaro C; Rovero P; Migliorini P
Lupus; 2015 Apr; 24(4-5):433-41. PubMed ID: 25801886
[TBL] [Abstract][Full Text] [Related]
28. Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
Orr C; Najm A; Biniecka M; McGarry T; Ng CT; Young F; Fearon U; Veale DJ
Arthritis Rheumatol; 2017 Nov; 69(11):2114-2123. PubMed ID: 28732135
[TBL] [Abstract][Full Text] [Related]
29. Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
Gudmann NS; Hansen NU; Jensen AC; Karsdal MA; Siebuhr AS
Autoimmunity; 2015 Mar; 48(2):73-9. PubMed ID: 25520183
[TBL] [Abstract][Full Text] [Related]
30. [Strong inflammation is essential for expression of articular cartilage-specific citrullinated antigens].
Qin G; Lin X; Liang P; Li Y; Zhou C; Kutty SN; Rikard H
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1081-1089. PubMed ID: 32895186
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice.
Svelander L; Erlandsson-Harris H; Astner L; Grabowska U; Klareskog L; Lindstrom E; Hewitt E
Eur J Pharmacol; 2009 Jun; 613(1-3):155-62. PubMed ID: 19358841
[TBL] [Abstract][Full Text] [Related]
32. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
Luban S; Li ZG
Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
[TBL] [Abstract][Full Text] [Related]
33. Is there a link between carbamylation and citrullination in periodontal disease and rheumatoid arthritis?
Bright R; Proudman SM; Rosenstein ED; Bartold PM
Med Hypotheses; 2015 Jun; 84(6):570-6. PubMed ID: 25801344
[TBL] [Abstract][Full Text] [Related]
34. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
Vossenaar ER; Radstake TR; van der Heijden A; van Mansum MA; Dieteren C; de Rooij DJ; Barrera P; Zendman AJ; van Venrooij WJ
Ann Rheum Dis; 2004 Apr; 63(4):373-81. PubMed ID: 15020330
[TBL] [Abstract][Full Text] [Related]
35. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
[TBL] [Abstract][Full Text] [Related]
36. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
37. Putative approaches to bypass the citrulline-specific autoimmune response in rheumatoid arthritis.
Gertel S; Amital H
Isr Med Assoc J; 2014 Sep; 16(9):587-90. PubMed ID: 25351021
[TBL] [Abstract][Full Text] [Related]
38. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
[TBL] [Abstract][Full Text] [Related]
39. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint.
Lippross S; Moeller B; Haas H; Tohidnezhad M; Steubesand N; Wruck CJ; Kurz B; Seekamp A; Pufe T; Varoga D
Arthritis Rheum; 2011 Nov; 63(11):3344-53. PubMed ID: 21769848
[TBL] [Abstract][Full Text] [Related]
40. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
